骨髓灰质炎和冠状病毒疾病2019:伊朗的一份报告
Masoud Etemadifar1, Mahsa Akafzadeh-Savari2, Mehri Salari3
1Department of Neurosurgery, Al-Zahra University Hospital, Isfahan University of Medical Sciences, Isfahan, Iran.
Current journal of neurology
|November 27, 2023
概括
患有骨髓质疏松症 (MG) 的患者不会面临更高的COVID-19风险. 这项研究没有根据年龄或甲状腺切除状态在MG患者中发现2019年冠状病毒病 (COVID-19) 的易感性或严重性增加.
科学领域:
- 神经学 神经学
- 传染性疾病 传染性疾病
- 免疫学 免疫学 免疫学
背景情况:
- 冠状病毒疾病2019 (COVID-19) 是一个具有显著死亡率的全球流行病.
- 伴随性疾病可能会使COVID-19的结果变得更糟.
- 骨髓灰质炎 (MG) 是一种神经肌肉结合障碍,理论上由于呼吸系统的损害而构成严重COVID-19的风险.
研究的目的:
- 为了调查COVID-19感染的模式在患有骨髓质疏松症的患者.
- 评估MG患者是否表现出COVID-19的易感性或严重性增加.
- 为了评估年龄,甲状腺切除状态和疾病持续时间对MG患者COVID-19结果的影响.
主要方法:
- 一项前性队列研究,涉及150名患有骨髓灰质炎的患者.
- 监测参与者六个月的COVID-19感染的迹象和症状.
- 在COVID-19感染的MG患者和未感染的MG患者之间进行比较分析.
主要成果:
- 在MG患者和对照人群之间没有观察到COVID-19易感性的统计学上显著差异.
- 在MG患者中,COVID-19的严重程度没有根据年龄,MG的持续时间或甲状腺切除术状态而增加.
- 分析没有显示MG临床状态和COVID-19结果之间的相关性.
结论:
- 骨髓灰质炎似乎不会增加对COVID-19的易感性或严重性.
- 年龄,甲状腺切除术状态和疾病持续时间等因素没有影响研究的MG人群中的COVID-19结果.
- 这些发现表明,MG患者可能不需要超出一般建议的特定COVID-19管理调整.
相关概念视频
Myasthenia Gravis: Overview and Treatment
1.5K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.5K
Myasthenia Gravis: Diagnostic Tests
890
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
890
Disorders of the Skeletal Muscle
966
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
966
Chemical Synapses
8.8K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
8.8K
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K


